Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,497 | 42,461 | 31,743 | 32,482 | 63,025 |
| Marketable Securities | 124,526 | 147,315 | 171,505 | 187,646 | 190,992 |
| Receivables | 1,384 | 1,784 | 1,579 | 1,116 | 847 |
| TOTAL | $173,463 | $195,569 | $209,714 | $228,782 | $260,955 |
| Non-Current Assets | |||||
| PPE Net | 12,411 | 13,192 | 11,355 | 11,293 | 11,392 |
| Intangibles | 172,239 | 172,463 | 28,999 | 29,252 | 29,506 |
| Other Non-Current Assets | 1,935 | 2,134 | 1,879 | 1,879 | 78 |
| TOTAL | $186,585 | $187,789 | $42,233 | $42,424 | $40,976 |
| Total Assets | $360,048 | $383,358 | $251,947 | $271,206 | $301,931 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,940 | 4,826 | 4,378 | 4,360 | 4,239 |
| Accounts payable and accrued liabilities | 2,660 | 1,740 | 1,019 | 706 | 2,637 |
| Accrued Expenses | 19,424 | 28,657 | 13,233 | 14,937 | 18,431 |
| TOTAL | $27,024 | $35,223 | $18,630 | $20,003 | $25,307 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 85,188 | 82,704 | 16,225 | 16,494 | 16,592 |
| TOTAL | $85,188 | $82,704 | $16,225 | $16,494 | $16,592 |
| Total Liabilities | $112,212 | $117,927 | $34,855 | $36,497 | $41,899 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,344 | 8,218 | 6,753 | 6,706 | 6,585 |
| Common Shares | 124 | 121 | 101 | 99 | 99 |
| Retained earnings | -753,747 | -719,486 | -687,179 | -657,581 | -625,629 |
| Other shareholders' equity | 2,562 | 2,541 | 2,610 | 2,723 | 2,687 |
| TOTAL | $247,836 | $265,431 | $217,092 | $234,709 | $260,032 |
| Total Liabilities And Equity | $360,048 | $383,358 | $251,947 | $271,206 | $301,931 |